Biotech pharma

Biodock

Website

Biodock's cloud platform accelerates microscopy analysis, automating months of microscopy analysis and infrastructure to minutes with our end-to-end AI architecture. Scientists enjoy auto-scaling storage, GPU compute, and 30-50% more accurate analysis. We're building an amazing experience to translate microscopy images to therapeutic insights f

Founded 2020Origin source ↗Checked 2026-09-15

Overview

Biodock's cloud platform accelerates microscopy analysis, automating months of microscopy analysis and infrastructure to minutes with our end-to-end AI architecture. Scientists enjoy auto-scaling storage, GPU compute, and 30-50% more accurate analysis.

We're building an amazing experience to translate microscopy images to therapeutic insights for academic and enterprise scientists.

Company description As recorded 2026-11-08
LinkedIn
Biotech pharmaAnalyticsBusinessesSubscription

Product & workflow

Our interactive viewer allows you to visualize detected objects with overlays and dive into quantitative metrics like area and signal intensity.

Source-reported As recorded 2026-09-23

Founders & team

Previously Biodock AI

Company history As recorded 2026-11-08

Nurlybek Mursaliyev

Founder

I have a Ph.D. in Cell and Molecular Biology from the Stanford University Department of Biology. My research focus was on stem cell biology and embryo development. I have experienced firsthand the problem we are solving with Biodock while doing my Ph.D. Previously, I also co-founded a med-tech company SmartLens but decided to focus on my Ph.D. I am also a history nerd and love visiting historical places.

X
Founder profile As recorded 2026-09-15
8team members reported
Source-reported As recorded 2026-09-15

Founded 2020 · Source

News & product activity

Sources & observations

Andreessen Horowitz · Y Combinator

Profile depthverified profile
Website observationwebsite reachable
Last website check2026-11-11
Location · source statedAustin, TX, USA
Pricing evidenceNo pricing page confirmed
Maturity: Not assessed · 3 of 6 areas documented

Source-based assessment · automated evidence rules

The retained text does not establish product availability or customer use.

Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.

Stage definitions
independent websitesource corroborationreachable websitedescriptive evidenceclassified market and modelsourced peoplesourced founding year
startup.observe Directory coverage · Sources & method